FDA Inspection 1114199 — Matthew 7:25 Inc dba Thrive Pharmacy
The FDA completed an inspection of Matthew 7:25 Inc dba Thrive Pharmacy on December 20, 2019 in Jacksonville, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- December 20, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jacksonville, FL (United States)